Lojas Quero-Quero (BSP:LJQQ3) reported resilient growth and strategic expansion during its Q2 2026 earnings call, navigating a challenging macroeconomic landscape through disciplined cost management, a […]
Is Gartner (IT) Using Buybacks to Mask Slowing Growth?
Gartner Inc. (IT) is aggressively repurchasing shares—retiring over 41% of its stock since 2015—to bolster earnings per share (EPS) as it faces mounting pressure from […]
Travel + Leisure CEO Sells Stock: What Investors Must Know
Travel + Leisure Co. (NYSE:TNL) CEO Michael Dean Brown sold 4,150 shares of company stock on August 5, according to a recent SEC Form 4 […]
PubMatic Stock Fair Value Jumps to $17.20 After Q2 Surge
PubMatic (PUBM) has seen its fair value estimate surge from US$12.89 to US$17.20, following a robust second-quarter performance that signals an accelerated return to growth […]
Embraer Hits Record Q2 Revenue: Guidance Raised After Surge
Embraer (EMBJ) delivered its strongest second-quarter revenue in history, backed by a 16-year high in quarterly deliveries and a record-breaking backlog for the seventh consecutive […]
Stanley Black & Decker Beats Q2 Earnings; Growth Strategy Pays Off
Stanley Black & Decker (SWK) reported a robust second quarter for 2026, with adjusted earnings per share of $1.57, exceeding the midpoint of its guidance […]
Meta Ordered to Pay $942M in Landmark Child Safety Ruling
A New Mexico judge ordered Meta to pay $942 million in total damages on Thursday, following a two-phase trial that concluded the company failed to […]
Voyager Stock Soars 70% on Explosive Q2 Growth
Voyager Technologies (NYSE: VOYG) saw its stock price climb approximately 70% this past week after the aerospace firm reported robust second-quarter growth metrics that significantly […]
Stepan Q2 2026 Earnings: Profits Surge 102% Amid Growth
Stepan Company (SCL) reported a robust second quarter for 2026 on Wednesday, July 29, with net income soaring 102% to $22.9 million, or $1.00 per […]
Halozyme (HALO) Soars 25% on Revenue Hike and Buybacks
Halozyme Therapeutics (HALO) shares surged 24.9% following the company’s decision to raise its 2026 revenue guidance and aggressively increase share buybacks, signaling confidence in the […]